DESOXY

4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.

Not to be confused with Desoxyn.
DESOXY
Names
Preferred IUPAC name
2-(3,5-Dimethoxy-4-methylphenyl)ethan-1-amine
Other names
3,5-Dimethoxy-4-methylphenethylamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C11H17NO2/c1-8-10(13-2)6-9(4-5-12)7-11(8)14-3/h6-7H,4-5,12H2,1-3H3 checkY
    Key: LLHRMWHYJGLIEV-UHFFFAOYSA-N checkY
  • InChI=1/C11H17NO2/c1-8-10(13-2)6-9(4-5-12)7-11(8)14-3/h6-7H,4-5,12H2,1-3H3
    Key: LLHRMWHYJGLIEV-UHFFFAOYAV
  • Cc1c(cc(cc1OC)CCN)OC
Properties
C11H17NO2
Molar mass 195.26 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

Effects

The effects of DESOXY vary significantly from mescaline, despite their chemical similarity.

Dosage

A typical dosage is within the range of 40–120 mg and lasts 6–8 hours.[1]

Legality

In 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.

DESOXY is also an isomer of 2C-D which makes it a schedule 1 drug in the United States.

References
  1. Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.